Canada’s Gold Standard in Independent Peptide Analysis
HPLC & MS Analysis
Comprehensive high-performance liquid chromatography and mass spectrometry to verify exact molecular identity and purity.
Verified COA Reports
Viewable, full-spectrum Certificates of Analysis for every batch so you can inspect precise test results instantly.
Canadian Standards
Reliable third-party testing conducted directly in Canada to keep your research or operations moving without border delays.
Accurate Peptide Analysis You Can Trust
High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to verify precise molecular weight and sample purity.
Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Transparent, easy-to-read batch reports providing full analytical verification for your research and documentation needs.
Industry Partners
| # | Common Name | Scientific / Chemical Name |
|---|---|---|
| 1 | BPC-157 | Pentadecapeptide BPC 157 (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) |
| 2 | TB-500 | Thymosin Beta-4 Fragment (Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser) |
| 3 | Semaglutide | [Aib8,Arg34]-GLP-1(7-37) hexadecanedioic acid derivative |
| 4 | Tirzepatide | GIP/GLP-1 receptor co-agonist synthetic peptide sequence |
| 5 | Retatrutide | GIP/GLP-1/Glucagon tri-agonist peptide derivative |
| 6 | CJC-1295 DAC | Tetrasubstituted 30-amino acid Growth Hormone Releasing Hormone with Drug Affinity Complex |
| 7 | CJC-1295 No DAC | Mod GRF 1-29 (Tetrasubstituted GRF 1-29) |
| 8 | Ipamorelin | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| 9 | GHRP-2 | D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2 (Pralmorelin) |
| 10 | GHRP-6 | His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 |
| 11 | Hexarelin | His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2 |
| 12 | Sermorelin | GHRH (1-29) amide |
| 13 | Tesamorelin | trans-3-Hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 |
| 14 | AOD-9604 | Tyr-hGH177-191 amide derivative |
| 15 | Epithalon | Ala-Glu-Asp-Gly (Epitalon) |
| 16 | GHK-Cu | Glycyl-L-histidyl-L-lysine copper complex |
| 17 | Melanotan I | [Nle4, D-Phe7]-alpha-MSH |
| 18 | Melanotan II | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 |
| 19 | PT-141 | Bremelanotide (Ac-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH) |
| 20 | Selank | Thr-Lys-Pro-Arg-Pro-Gly-Pro |
| 21 | Semax | Met-Glu-His-Phe-Pro-Gly-Pro |
| 22 | DSIP | Delta Sleep-Inducing Peptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) |
| 23 | Oxytocin | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 (disulfide bridge) |
| 24 | KPV | Lys-Pro-Val tripeptide fragment of alpha-MSH |
| 25 | LL-37 | Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser |
| 26 | SS-31 | D-Arg-Dmt-Lys-Phe-NH2 (Elamipretide) |
| 27 | MOTS-c | Mitochondrial Open Reading Frame of the 12S rRNA-c (16-amino acid peptide) |
| 28 | Humanin | Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Aib |
| 29 | Follistatin 315 | Recombinant human Follistatin isoform 315 |
| 30 | Follistatin 344 | Recombinant human Follistatin isoform 344 |
| 31 | ACE-031 | ACVR2B-Fc soluble fusion protein |
| 32 | IGF-1 LR3 | Long Arg3 Insulin-like Growth Factor-1 |
| 33 | IGF-1 DES | DES(1-3) Insulin-like Growth Factor-1 |
| 34 | MGF | Mechano Growth Factor (IGF-1Ec peptide) |
| 35 | PEG-MGF | Pegylated Mechano Growth Factor |
| 36 | Cagrilintide | Long-acting amylin analogue |
| 37 | Liraglutide | [Arg34, Gly8]-GLP-1(7-37) derivative with gamma-glutamic acid-palmitoyl spacer |
| 38 | Exenatide | Exendin-4 (His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2) |
| 39 | Dulaglutide | GLP-1 receptor agonist Fc fusion protein |
| 40 | P21 | Ac-Val-Gly-Asp-Gly-D-Ala-Pro-NH2 derivative |
| 41 | Cerebrolysin | Porcine neuropeptide preparation / peptide mixture |
| 42 | Cortexin | Polypeptide complex extracted from cerebral cortex |
| 43 | Pinealon | Glu-Asp-Arg tripeptide |
| 44 | Vilon | Lys-Glu dipeptide |
| 45 | Thymulin | Pyr-Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH |
| 46 | Thymopentin | Arg-Lys-Asp-Val-Tyr (TP-5) |
| 47 | TA1 | Thymosin Alpha-1 (Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH) |
| 48 | Bivalirudin | D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu |
| 49 | Eptifibatide | N6-(aminoiminomethyl)-N2-(1-oxooctyl)-L-lysyl-L-cysteinyl-S-S-cyclic |
| 50 | Nesiritide | Recombinant human B-type natriuretic peptide (32-amino acid) |
| 51 | Leuprolide | 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide |
| 52 | Goserelin | pyroGlu-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azgly-NH2 |
| 53 | Triptorelin | [D-Trp6]-LHRH |
| 54 | Histrelin | [D-His(N-benzyl)6, Pro9-N-ethylamide]-LHRH |
| 55 | Degarelix | GnRH receptor antagonist peptide derivative |
| 56 | Cetrorelix | Ac-D-Nal-D-Cpa-D-Pal-Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH2 |
| 57 | Ganirelix | Ac-D-Nal-D-Cpa-D-Pal-Ser-Tyr-D-Har(Et)2-Leu-Har(Et)2-Pro-D-Ala-NH2 |
| 58 | Octreotide | D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol (cyclic disulfide) |
| 59 | Lanreotide | D-2Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 (cyclic disulfide) |
| 60 | Pasireotide | Cyclic hexapeptide somatostatin analogue |
| 61 | Teriparatide | Recombinant human parathyroid hormone fragment (1-34) |
| 62 | Abaloparatide | Synthetic PTHrP(1-34) analogue derivative |
| 63 | Calcitonin (Salmon) | 32-amino acid linear polypeptide sequence |
| 64 | Linaclotide | 14-amino acid cyclic peptide with 3 disulfide bonds |
| 65 | Plecanatide | 16-amino acid cyclic peptide guanylate cyclase-C agonist |
| 66 | Teduglutide | [Gly2]-GLP-2 analogue |
| 67 | Ziconotide | omega-Conotoxin MVIIA synthetic peptide |
| 68 | Vasopressin | Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2 (disulfide bridge) |
| 69 | Desmopressin | 1-deamino-8-D-arginine vasopressin (DDAVP) |
| 70 | Terlipressin | Nalpha-triglycyl-8-lysine-vasopressin |
| 71 | Carbetocin | 1-deamino-1-monocarba-[2-O-methyltyrosine]-oxytocin |
| 72 | Atosiban | 1-deamino-2-(O-ethyl-D-tyrosine)-4-threonine-8-ornithine-oxytocin |
| 73 | Sincalide | Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2 (CCK-8) |
| 74 | Secretin (Human) | 27-amino acid peptide hormone |
| 75 | Glucagon | 29-amino acid pancreatic peptide hormone |
| 76 | Sipuleucel-T antigen | PAP-GM-CSF fusion peptide domain |
| 77 | Albiglutide | Dipeptidyl peptidase-4 resistant GLP-1 dimer fused to human albumin |
| 78 | Pramlintide | [25,28,29-Proline]-human amylin |
| 79 | Afamelanotide | [Nle4, D-Phe7]-alpha-MSH (NDP-alpha-MSH) |
| 80 | Angiotensin II | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe |
| 81 | Bradykinin | Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg |
| 82 | Substance P | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
| 83 | Neurotensin | pyroGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu |
| 84 | Bombesin | pyroGlu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 |
| 85 | Dynorphin A | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln |
| 86 | Leu-Enkephalin | Tyr-Gly-Gly-Phe-Leu |
| 87 | Met-Enkephalin | Tyr-Gly-Gly-Phe-Met |
| 88 | Beta-Endorphin | 31-amino acid endogenous opioid neuropeptide |
| 89 | Neuropeptide Y | 36-amino acid neural peptide sequence |
| 90 | VIP | Vasoactive Intestinal Peptide (28-amino acid) |
| 91 | PACAP-38 | Pituitary Adenylate Cyclase-Activating Polypeptide-38 |
| 92 | Ghrelin | 28-amino acid n-octanoylated peptide hormone |
| 93 | Obestatin | 23-amino acid ghrelin-gene derived peptide |
| 94 | Kisspeptin-10 | Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 |
| 95 | Kisspeptin-54 | 54-amino acid metastin fragment |
| 96 | GnRH | pyroGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 (Gonadorelin) |
| 97 | CILP Fragment | Cartilage Intermediate Layer Protein functional peptide domain sequence |
| 98 | Palmitoyl Pentapeptide-4 | Pal-Lys-Thr-Thr-Lys-Ser (Matrixyl) |
| 99 | Palmitoyl Tripeptide-1 | Pal-Gly-His-Lys |
| 100 | Acetyl Hexapeptide-8 | Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2 (Argireline) |